Contents
On this page
- Functions of the case report
- Detection of novel clinical phenomena
- Progression from case observation to clinical trial
- Level 4 of the evidence hierarchy and its meaning
- Claims supported by a single case
- Pooling of case reports and its dependence on reporting quality
- Publication volume and its implications for submission
- Research questions unsuited to the case report format
- Limitations of this article
- Key points
- Application to your study
- Frequently asked questions
Academy · Research Writing · uses of case reports
The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations
A case report is an instrument of detection rather than of evidence. Its purpose is to identify a phenomenon, such as a new disease, an unexpected drug effect or a previously undescribed presentation, and to describe it with sufficient precision that others can look for it. It cannot establish that a treatment is effective, and the most common failure in published case reports is a discussion section that implies otherwise.
Case reports are the most frequently published and least highly regarded article type in medicine. More than 77,000 were indexed in PubMed in 2022, and more than 2.4 million exist across MEDLINE databases; trainees are commonly advised both to write them and that they do not count as evidence. Both positions are partly correct, and they are reconciled by specifying the function of the report. A case report answers the question of whether a phenomenon has ever been observed; it does not answer questions of frequency or comparison. Almost every misuse of the format arises from asking it the second type of question.
Learning objectives
- The distinct functions of a case report, and how to identify the function of a given report
- Why case reports sit at Level 4 in the Oxford CEBM hierarchy, and what that ranking does and does not mean
- How a single case generates a hypothesis that a trial can test, and how frequently this occurs
- The difference between a claim that a single case supports and a claim that it merely raises
- What pooled case report data can be used for, and the reporting conditions that make pooling possible
- Which research questions are better addressed by designs other than a case report
Common misconceptions
- “Case reports do not constitute real evidence.” They constitute evidence of occurrence, which is a legitimate category. A case report establishes that a phenomenon exists; it cannot establish frequency, effect or comparison. Dismissing the format entirely would discard the only instrument medicine has for detecting genuinely novel phenomena.
- “Level 4 means low quality.” The Oxford CEBM levels rank designs by their capacity to answer questions about treatment effects, with Level 1a representing a systematic review of homogeneous randomised trials and Level 5 expert opinion without explicit critical appraisal. Case reports and case series are placed at Level 4 of the five levels. This ranking indicates which question the design can answer; it is not an assessment of the quality of an individual report.
- “This case shows the drug was effective.” Improvement in one patient after treatment does not distinguish a treatment effect from natural history, regression to the mean, concurrent therapy or chance. The strongest defensible claim is a temporal association in one patient, together with a rationale for further investigation.
- “A case report is a straightforward option because it does not seek to prove anything.” Because nothing is proved, the value of the report depends entirely on the quality of the description. The CARE checklist, developed through a three-phase consensus process involving 27 participants, specifies 13 items for this reason, and approximately 76% of journals publishing case reports do not explicitly enforce reporting standards, so rigour must be supplied by the author.
- “Case reports are not read.” Clinicians search for case reports when managing a patient whose presentation is atypical, which is when the literature is most useful and most often lacking. The readership is small, specific and purposeful.
Functions of the case report
It is more productive to ask not whether case reports are good evidence but what they are instruments for. Five functions should be distinguished, because each implies a different structure, a different literature search and a different final paragraph.
Detection. Reporting the first instance of a phenomenon — a new disease, a new organism, a new adverse effect, a new presentation of an established condition. This is the function that case reports perform and no other design can, because every other design must specify in advance what it is seeking 16,35.
Characterisation. Adding detail to a condition that is known but poorly described, typically a rare one for which the published literature consists of a small number of reports and each further report materially changes what a clinician expects 26.
Falsification. Reporting a case that contradicts a stated rule. If the textbook states that a condition does not occur in a population, one well-documented case in that population is sufficient to require revision of that statement. A single counter-example is logically powerful in a way that a single confirming example never is 37.
Hypothesis generation. Describing an association in one patient with sufficient mechanistic reasoning that a study can be designed to test it.
Teaching. Using a real case to illustrate clinical reasoning, which is a legitimate published purpose and also the reason that case reports predominate in trainee writing 9,11. Our page on case reports as a teaching vehicle covers what the survey evidence says about that use.
Identifying the function of the report is not a formality. The success of a detection report depends on the completeness of the diagnostic work-up and the thoroughness of the search that establishes novelty. A falsification report depends on the precision with which the contradicted claim is quoted. A teaching report requires the reasoning to be visible, including the incorrect steps. Writing a report for one function and submitting it as another is a common reason for rejection.
The five jobs, and the claim each one supports
| Job | What the report has to get right | The claim it supports | The claim it does not |
|---|---|---|---|
| Detection — something not previously described | Completeness of the diagnostic work-up; a stated, wide literature search behind the novelty claim | This phenomenon occurs, and this is how it presented | How often it occurs, or in whom it is more likely |
| Characterisation — a rare condition poorly described | Structured timeline, exact investigations and values, follow-up duration | The phenotype includes these features, in this sequence | The typical course, which needs a series or a registry |
| Falsification — a case that contradicts a stated rule | The contradicted claim quoted precisely, and the case documented to a standard that withstands doubt | The rule as stated is not universal | A revised rule — one counter-example removes a claim, it does not build one |
| Hypothesis generation — an association worth testing | Mechanistic reasoning, alternatives considered, and a named feasible study design | This association is worth investigating, by this design | That the association is causal, or that the treatment works |
| Teaching — clinical reasoning made visible | The reasoning shown, including the incorrect steps; the learning point stated explicitly | This is how the problem should be worked through | Anything about effectiveness or frequency |
A working taxonomy for authors, not a published classification. It is compiled from the uses described in the case report methods literature and from the CARE statement’s account of what case reports contribute.
Detection of novel clinical phenomena
The strongest argument for case reports is historical. The first published signal of what became the AIDS epidemic was a 1981 MMWR report of Pneumocystis pneumonia cases in Los Angeles — a description of patients who would not have been expected to have that infection, published because clinicians recognised a pattern that no surveillance system was configured to detect 38. No trial, cohort or registry could have produced that signal, because none of them was designed to look for it.
The mechanism is generalisable. A case report can detect any phenomenon whose defining feature is that it was not anticipated: an off-target drug effect, a novel pathogen, an interaction, a late complication of a procedure, an atypical course in a particular patient group 16,31. Detection depends on a clinician recognising an unexpected finding and recording it in sufficient detail for a second clinician to recognise it.
A recent and smaller example illustrates the same pattern at a clinical scale. In a single renal transplant recipient with COVID-19, nasopharyngeal swabs took 70 days to reach two consecutive negative results, against a median of about 10 days in a cited retrospective study 5. One patient cannot indicate how common prolonged shedding is in immunosuppressed recipients. The case does indicate that 70 days is possible, which is immediately relevant to isolation or clearance policy for that population, and it is a sufficiently specific observation to serve as the basis for a study. Our worked example of a transplant COVID-19 case report takes that same case through the consent and de-identification problems it raises.
Two practical implications follow. First, the value of a detection report is proportional to the completeness of the description, not to the severity of the outcome — a sparse report of a striking case is of less value than a detailed report of a subtle anomaly. Second, a novelty claim is a claim about the literature, so the search that supports it must be genuine and must be described. “To our knowledge the first reported case” with no stated search is an assertion, not a finding.
Progression from case observation to clinical trial
Hypothesis generation is the use most often claimed and least often examined. There is at least one direct measurement of it: an editorial on case report publishing cites a Lancet study finding that 17% of its case reports led to clinical trials 21. The figure requires careful interpretation in both directions.
On the one hand, it is notable. Roughly one in six case reports in one high-profile journal was followed by a trial. For an article type routinely described as anecdotal, a one-in-six rate of generating testable research is a strong defence of the format.
On the other hand, it means that five in six did not, and the figure comes from a journal whose case report selection is unusually stringent 32. Nothing justifies extending the 17% figure to case reports in general, and this page does not do so. The figure does support a change in how the final paragraph is written: if roughly one in six reports in a highly selected set leads to a study, then the question of what study the case would justify is a substantive question with a measurable answer rate, not a rhetorical closing statement.
In practice, a hypothesis-generating report should conclude with a study design rather than a general aspiration. The population, the comparison, the outcome and the feasible design — a registry analysis, a case-control study, a prospective cohort — should be named. Our pages on case-control studies, cohort studies and epidemiological designs for clinical trials cover what each design can answer, which is what allows that final paragraph to be specific rather than vague.
Level 4 of the evidence hierarchy and its meaning
Under the Oxford Centre for Evidence-Based Medicine system, case reports and case series sit at Level 4 of five levels. Level 1a is a systematic review of homogeneous randomised trials; Level 5 is expert opinion without explicit critical appraisal 41. Case reports are therefore near the bottom of the hierarchy but above unappraised opinion, and understanding the reasons for this position is more useful than memorising it.
The hierarchy ranks designs by their capacity to support a causal claim about a treatment effect 6,13. The features that raise a design in the ranking are a comparison group, prospective allocation, blinding, and a denominator — a defined population from which the observed cases arose. A case report has none of these by construction. It has a numerator and no denominator, which is precisely why it cannot address frequency 6.
This is a statement about one question. When the question changes, the hierarchy changes accordingly. For the question of whether a drug lowers mortality, a case report contributes very little and a randomised trial is close to definitive. For the question of whether a drug can cause a rare reaction at all, a case report may be the only available evidence, and a randomised trial powered for mortality will usually have been too small and too short to detect it. The hierarchy is a tool for grading answers to effectiveness questions, not a ranking of article types, and citing Level 4 as a reason to discount a detection report is a misapplication of it.
One consequence for authors is that the discussion should not argue against the ranking. It should accept the ranking and then state what the case does establish. A paragraph that concedes the limitation of the design and then states a narrow, defensible claim is considerably more persuasive than one that asks for the case to be taken as more than it is.
Claims supported by a single case
Most weak case reports fail at the same point, and it is not the clinical description. It is the sentence in the discussion that converts an observation into a recommendation. The conversion is usually unintentional: the author has treated the patient, the patient improved, and the improvement appears to be a result.
The appropriate test for a draft is to ask what else could have produced the observed course. For a single treated patient who improved, the plausible alternatives are always the same: the natural history of the condition, concurrent treatments, the tendency of patients to present at their most severe point and improve regardless, measurement variation, and chance 19,22. A case report cannot exclude any of them. It can, however, document the sequence precisely, note the alternatives explicitly, and state what would distinguish between them.
There is a narrow exception. Where a treatment is withdrawn and the finding resolves, then reintroduced and the finding recurs, the within-patient sequence is considerably more informative than a single exposure; where this has occurred, it should be reported in that structure, because it is the strongest causal signal a single patient can provide 22,31. Such a sequence should not be constructed retrospectively, nor implied where only one exposure occurred.
The CARE checklist assists here in a way that is easily overlooked. By requiring a structured account of the timeline, interventions, outcomes and follow-up as separate items, it makes the gap between what was observed and what is being claimed visible on the page 10,17. Our CARE guidance for case reports sets out the items.
The discussion paragraph of a single-patient report
Treats one patient as a result
In conclusion, this case demonstrates that intravenous immunoglobulin is an effective and well-tolerated treatment option in this setting. Clinicians should consider early initiation of therapy in similar patients, as our patient showed rapid clinical improvement with no adverse effects. To our knowledge this is the first reported case of this presentation.
“Demonstrates that it is effective” is not available from one patient. Natural history, the concurrent antibiotic, presentation at the most severe point of the illness and chance are all neither excluded nor mentioned.
“Clinicians should consider” is a practice recommendation. A recommendation requires a comparison group; this report has none, and it has no denominator to support any statement about who “similar patients” are.
“Well-tolerated” with no follow-up period stated. Tolerability is a claim that depends on time, and the time period is not stated.
The novelty claim has no search behind it. With more than 2.4 million case reports in MEDLINE databases, “to our knowledge the first” without a described search is the claim that a reviewer checks first and most often refutes.
No structured timeline. Nothing in this report could be pooled with another report of the same condition, because no comparable field has been recorded.
States the claim the case supports
We report a single patient in whom clinical improvement followed the initiation of intravenous immunoglobulin within 48 hours, with resolution of the presenting features by day 9 and no adverse events recorded over 6 months of follow-up. A single uncontrolled observation cannot distinguish a treatment effect from the natural history of the condition, from the effect of the concurrent antibiotic course, or from chance, and we make no claim about efficacy. The observation does support a testable hypothesis: that early immunoglobulin shortens time to resolution in this presentation. A case-control analysis within an existing registry, comparing time to resolution by treatment timing, would be feasible with the numbers such registries hold. Our search of MEDLINE, Embase and Scopus to 14 March 2024, with no language restriction, identified no previous report of this presentation in a patient of this age group; we state the claim at that level of specificity rather than as an absolute first.
The observation is reported as a sequence with dates and durations, which is what makes it verifiable and poolable.
The alternative explanations are named rather than left for the reviewer to raise, which pre-empts the most common objection.
The claim is reduced to a hypothesis but made more useful, because a specific design is proposed rather than a call for “further research”.
Tolerability is bounded by a stated follow-up period, so the reader knows what the absence of events does and does not cover.
The novelty claim is limited to what the search actually supports, which is both more defensible and more informative than an absolute first.
A reviewer assessing a case report is primarily determining whether the author distinguishes between what was observed and what it means. The second version addresses that question in its first sentence.
Pooling of case reports and its dependence on reporting quality
Aggregation is a use that has grown and remains underexploited. The CARE authors argue that systematically pooled case report data can help design clinical studies and flag early signals of benefit and harm 8,17. The rationale is straightforward: an individual case report has no denominator, but a set of reports collected systematically has a numerator large enough to describe a phenotype, a time course, a dose relationship or a demographic pattern — and these are precisely the parameters needed to power a definitive study.
This use has a strict precondition. Pooling is possible only if the individual reports contain the same fields, which is a problem of reporting standards rather than of methods. The CARE checklist, with its 13 items produced through a three-phase consensus process involving 27 participants, exists largely to make case reports comparable with one another rather than merely readable 17. In contrast, about 76% of journals publishing case reports do not explicitly enforce reporting standards, which is the largest single constraint on this use of the literature 1.
The implication for an individual author is modest but consequential. The structured clinical facts should be reported even where they appear incidental to the narrative: exact timings, doses and units, the specific diagnostic assay, the follow-up duration, the explicit outcome measure, and concomitant medications. These are the fields that a researcher aggregating 60 reports of the condition in five years will require, and they are the fields most often omitted from a narrative draft.
Publication volume and its implications for submission
More than 77,000 case reports were indexed in PubMed in 2022, and more than 2.4 million exist across MEDLINE databases 1. This volume has three consequences that authors should anticipate.
The first is that novelty is more difficult to claim than it appears. With a corpus of that size, “first reported case” claims frequently fail at review because a reviewer finds the earlier report in a journal or language that the author did not search. Authors should search widely, state exactly what was searched and when, and prefer a precise claim — first in this population, first with this exposure, first with this confirmatory test — over a sweeping one.
The second is that journals apply strict triage. Many general journals have effectively stopped publishing unsolicited case reports, and a large share of the literature now appears in dedicated case report journals with their own article-type definitions and word limits 33,36. Selecting the venue before drafting affects the structure of the manuscript, not merely its formatting. Our guidance on choosing a journal for a case report and on journal selection covers that decision.
The third is that, with about 76% of publishing journals not explicitly enforcing reporting standards, meeting the standard is at the discretion of the author. In practice, a CARE-complete report is distinctive, and the absence of a journal requirement does not indicate that the items are unimportant to a reader.
The scale of the case report literature and the extent to which reporting standards are enforced in it. Counts as reported in a published analysis of case report indexing and journal reporting requirements.
Research questions unsuited to the case report format
Some manuscripts are submitted as case reports because a case report is the available format, not because it is the appropriate one. Four patterns should be recognised early, because each is better suited to another format.
You are describing a cohort with a label problem. If consecutive patients have been collected from a defined population and the aim is to describe how often an outcome occurred, the manuscript is the beginning of a series or an observational study, and the number of patients that determines the article type is genuinely contested — see how many patients make a case series and the definitional differences between the two.
You want to compare. Any claim of the form “patients given A did better than patients given B” requires a comparison group assembled for the purpose. Two patients, one receiving each treatment, do not constitute such a group.
You want to estimate frequency. Frequency requires a denominator. If the population from which the case arose cannot be stated, a rate cannot be stated, and a case report should not contain one.
You are summarising the literature. A case report with a 15-reference discussion that reviews every published instance is a short review under the wrong label. The author should either report the case concisely or write the review as a review with a stated search strategy.
Limitations of this article
Three limitations should be acknowledged. First, the 17% figure for case reports leading to trials comes from one journal’s own experience and should not be read as a general rate; no comparable figure exists for the literature as a whole, and this page does not supply one 21.
Second, the claim that case reports detect novel phenomena rests substantially on a historical record of successes. The denominator — how many reports of apparent novelty turned out to be nothing — is not systematically known, which means the detection function cannot be quantified as a yield.
Third, the value of pooling case report data is argued by the CARE authors on mechanistic grounds and is plausible, but the gains depend on reporting completeness that the publishing system does not currently require 8,17. The 76% non-enforcement figure describes the obstacle; it does not indicate how much pooled analyses would improve if the obstacle were removed 1.
None of these limitations undermines the use of the format. They do, however, indicate that the strongest version of a case report’s argument is a narrow one, stated precisely, with the alternatives named. Our page on case reports in evidence-based practice covers how that narrow claim is used at the bedside, and the limits of case study designs sets out the boundary in more detail.
Key points
Key points
A case report is an instrument for detection and description, not for estimation or comparison. It has a numerator but no denominator, and therefore cannot address frequency; it has no comparison group, and therefore cannot address effect. For these reasons, it is placed at Level 4 of the five Oxford CEBM levels, above unappraised expert opinion and below designs intended to answer questions of effectiveness. Its distinctive contribution cannot be provided by other designs: the 1981 MMWR report of Pneumocystis pneumonia in Los Angeles was the first signal of the AIDS epidemic because no surveillance system was designed to detect it. Authors should identify which of the five functions the report serves, provide the structured clinical detail that permits later pooling, name the alternative explanations for the observed course, and conclude with the study that the case would justify rather than a recommendation it cannot support. One journal found that 17% of its case reports led to clinical trials, which provides stronger support for the format than any argument for its status as evidence of effect.
Application to your study
Application to your study
- The function of the report should be identified before drafting. The function, whether detection, characterisation, falsification, hypothesis generation or teaching, should be recorded at the outset, because it determines the structure and the final paragraph.
- A literature search should be completed before novelty is claimed. The search should cover multiple databases, without language restriction and with a stated end date, and the claim should be limited to what the search supports rather than asserting absolute priority.
- The timeline should be presented as structured data rather than narrative. It should include dates, intervals, doses with units, the specific assay, the explicit outcome measure and the duration of follow-up, which are the fields required by anyone aggregating reports.
- Alternative explanations should be listed during drafting. Natural history, concurrent treatment, presentation at the most severe point, measurement variation and chance should be addressed in the discussion before a reviewer raises them.
- Practice recommendations should be removed. The draft should be searched for phrases such as “clinicians should”, “demonstrates that”, “proves”, “effective and safe” and “we recommend”, and each replaced with a description of what was observed.
- The report should conclude with a proposed study design rather than a general aspiration. The population, comparison, outcome and feasible study type that the case would justify should be specified.
- The CARE items should be completed even where the journal does not require them. Most journals publishing case reports do not explicitly enforce reporting standards, so completeness is the responsibility of the author.
Frequently asked questions
There are five distinct functions, and authors should determine which one their report serves. Detection: reporting a phenomenon not previously described, which is the only function no other study design can perform, because every other design must specify in advance what it is seeking. Characterisation: adding detail to a rare condition that is known but sparsely described. Falsification: documenting a case that contradicts a stated rule, where one well-documented counter-example is logically sufficient. Hypothesis generation: describing an association with sufficient precision that a study can be designed to test it. Teaching: making clinical reasoning visible, which is a legitimate published purpose. Each function implies a different structure, a different literature search and a different closing paragraph, which is why a detection report submitted as a teaching report tends to be rejected.
They are evidence of occurrence, which is a legitimate but narrow category. Under the Oxford CEBM system, case reports and case series sit at Level 4 of five levels, with Level 1a a systematic review of homogeneous randomised trials and Level 5 expert opinion without explicit critical appraisal — near the bottom, therefore, but above unappraised opinion. The ranking measures a design’s capacity to support a causal claim about a treatment effect, and a case report has no comparison group and no denominator, so it ranks low on that question by construction. For the question of whether a phenomenon can occur at all, the case report may be the only evidence available, because trials powered for mortality are usually too small and too short to detect a rare event.
Sometimes, and the mechanism is specific. A case report changes practice when it falsifies an assumption of practice, or when it reveals a possibility that policy must accommodate. For example, in one renal transplant recipient with COVID-19, nasopharyngeal swabs took 70 days to reach two consecutive negatives, against a median of about 10 days in a cited retrospective study. That single observation cannot indicate how common prolonged shedding is, but isolation or clearance policy for immunosuppressed patients must now allow for the possibility of 70 days. A case report cannot change practice by showing that a treatment was effective in one patient — that requires a comparison group.
There is one real measurement: an editorial on case report publishing cites a Lancet study finding that 17% of its case reports led to clinical trials. Roughly one in six is a strong figure for an article type routinely dismissed as anecdotal. Two cautions apply. The figure comes from a single journal with unusually stringent case report selection, so it should not be read as a general rate for the literature, and no comparable figure exists for case reports overall. In addition, five in six did not lead to a trial. The practical value of the figure is that the question of what study a case would justify has a measurable answer rate, which supports concluding the discussion with a named design rather than a call for further research.
Volume and status measure different things. More than 77,000 case reports were indexed in PubMed in 2022 and more than 2.4 million exist across MEDLINE databases, because the supply is large — every clinician encounters anomalies, and a case report requires far less time than original research — and because the demand is genuine: clinicians search for case reports precisely when managing a patient with an atypical presentation, which is when the literature is most useful and most often lacking. The low ranking reflects the design’s inability to answer effectiveness questions, not the usefulness of the format for the questions it can answer. The principal practical problem created by this volume is that novelty claims are much more difficult to sustain than authors expect.
One test should be applied: all factors other than the intervention that could have produced the observed course should be listed. For a single treated patient who improved, the plausible alternatives are always natural history, concurrent treatments, the tendency of patients to present at their most severe point and improve regardless, measurement variation and chance. None of these can be excluded, so each should be named. The narrow claim that remains — a temporal association in one patient — should then be stated, and the design that would test it proposed. Terms such as “demonstrates”, “proves”, “effective and safe” and “clinicians should consider” should be removed. There is one narrow exception: if treatment was withdrawn, the finding resolved, treatment was reintroduced and the finding recurred, that sequence should be reported explicitly, because it is the strongest causal signal one patient can provide.
The CARE authors argue that systematically pooled case report data can help design clinical studies and flag early signals of benefit and harm. The rationale is sound: one report has no denominator, but a systematically collected set has enough cases to describe a phenotype, a time course or a dose relationship — the parameters required to power a definitive study. The precondition is that individual reports contain the same fields, which is a reporting problem. The CARE checklist’s 13 items, developed through a three-phase consensus involving 27 participants, exist largely to make reports comparable rather than merely readable. Since about 76% of journals publishing case reports do not explicitly enforce reporting standards, completeness is the author’s responsibility: exact timings, doses with units, named assays, follow-up duration, explicit outcome measures.
There are four indications. If the manuscript concerns consecutive patients from a defined population and aims to describe how often an outcome occurred, it is a series or an observational study, and the patient count that separates the two is genuinely contested. If outcomes are to be compared between treatments, a comparison group assembled for the purpose is required. If a frequency is to be stated, a denominator — a population from which the cases arose — is required, and if it cannot be named, no rate belongs in the paper. If the discussion reviews every published instance of the condition across fifteen references, the manuscript is a short review under the wrong label; the author should either shorten the report or write a full review with a stated search strategy.
References
- Valença MM, Prieto Peres MF, Ramos de Andrade J. Why case reports still matter: reclaiming their epistemic, ethical, and clinical value in contemporary publishing. Headache Medicine. 2026;17(1):72-74. doi:10.48208/HeadacheMed.2026.9 read 9 October 2026. doi.org/10.48208/HeadacheMed.2026.9
- Rosário C. A Importância da Publicação de Relatos de Casos (The Importance of Publishing Case Reports). 2024;2(2):47. doi:10.60591/crspmi.272 read 9 October 2026. doi.org/10.60591/crspmi.272
- Parums DV. Editorial: The increasing relevance of case reports in medical education and clinical practice - and how to write them. American Journal of Case Reports. 2023;24. doi:10.12659/AJCR.942670 read 9 October 2026. doi.org/10.12659/AJCR.942670
- Novoa NM. Editorial: Case-reports, a compendium of useful ideas for our daily activity. Frontiers in Surgery. 2022;9:1026401. doi:10.3389/fsurg.2022.1026401 read 9 October 2026. doi.org/10.3389/fsurg.2022.1026401
- Wu J, Xiong L, Li P. Coronavirus disease 2019 (COVID-19) in a Chinese renal transplant recipient: a case report. Translational Andrology and Urology. 2021;10(5):2140-2148. doi:10.21037/tau-21-314 read 9 October 2026. doi.org/10.21037/tau-21-314
- Aquilina J, Neves JB, Tran MGB. An overview of study designs. British Journal of Hospital Medicine. 2020. doi:10.12968/hmed.2020.0127 read 9 October 2026. doi.org/10.12968/hmed.2020.0127
- Arpali E, Akyollu B, Yelken B, Tekin S, Turkmen A, Kocak B. Case report: A kidney transplant patient with mild COVID-19. Transplant Infectious Disease. 2020;22(4):e13296. doi:10.1111/tid.13296 read 9 October 2026. doi.org/10.1111/tid.13296
- Sampayo-Cordero M, et al. Agreement between results of meta-analyses from case reports and clinical studies, regarding efficacy and safety of laronidase therapy in patients with mucopolysaccharidosis type I. Molecular Genetics and Metabolism. 2018;123(2). doi:10.1016/j.ymgme.2018.01.002 read 9 October 2026. doi.org/10.1016/j.ymgme.2018.01.002
- Packer CD, Katz RB, Iacopetti CL, Krimmel JD, Singh MK. A case suspended in time: the educational value of case reports. Academic Medicine. 2017;92(2):152-156. doi:10.1097/ACM.0000000000001199 read 9 October 2026. doi.org/10.1097/ACM.0000000000001199
- Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: explanation and elaboration document. Journal of Clinical Epidemiology. 2017;89:218-235. doi:10.1016/j.jclinepi.2017.04.026 read 9 October 2026. doi.org/10.1016/j.jclinepi.2017.04.026
- Florek AG, Dellavalle RP. Case reports in medical education: a platform for training medical students, residents, and fellows in scientific writing and critical thinking. Journal of Medical Case Reports. 2016;10:86. doi:10.1186/s13256-016-0851-5 read 9 October 2026. doi.org/10.1186/s13256-016-0851-5
- Akers KG, Shidham VB. CytoJournal Quiz Cases: publishing open-access, PubMed-searchable cytopathology cases with educational messages. CytoJournal. 2016;13:15. doi:10.4103/1742-6413.187015 read 9 October 2026. doi.org/10.4103/1742-6413.187015
- Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evidence-Based Medicine. 2016;21:125-127. doi:10.1136/ebmed-2016-110401 read 9 October 2026. doi.org/10.1136/ebmed-2016-110401
- Mlakar J, Korva M, Tul N, Popovic M, Poljsak-Prijatelj M, Mraz J, et al. Zika virus associated with microcephaly. New England Journal of Medicine. 2016;374:951-958. read 9 October 2026. cytojournal.com
- Paz-Pacheco E. The case for case reports: valuable resource in ASEAN. Journal of the ASEAN Federation of Endocrine Societies. 2015;30(1):5-6. doi:10.15605/jafes.030.01.12 read 9 October 2026. doi.org/10.15605/jafes.030.01.12
- Ranganathan P, Bavdekar SB, Pramesh CS. Writing case reports for ecancer. ecancermedicalscience. 2015;9:ed49. doi:10.3332/ecancer.2015.ed49 read 9 October 2026. doi.org/10.3332/ecancer.2015.ed49
- Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case report guideline development. Journal of Clinical Epidemiology. 2014;67(1):46-51. doi:10.1016/j.jclinepi.2013.08.003 read 9 October 2026. doi.org/10.1016/j.jclinepi.2013.08.003
- Bhattacharyya S, Miller J, Ropper AH. The case for case reports. Annals of Neurology. 2014;76:484-486. read 9 October 2026. cytojournal.com
- Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Research Notes. 2014;7:264. doi:10.1186/1756-0500-7-264 read 9 October 2026. doi.org/10.1186/1756-0500-7-264
- Nissen T, Wynn R. The history of the case report: a selective review. JRSM Open. 2014;5(4):2054270414523410. doi:10.1177/2054270414523410 read 9 October 2026. doi.org/10.1177/2054270414523410
- Buscemi D, Cevik C. Case Reports: Yes or No. The Southwest Respiratory and Critical Care Chronicles. 2013;1(3):1-3. doi:10.12746/swrccc2013.0103.025 read 9 October 2026. doi.org/10.12746/swrccc2013.0103.025
- Kiene H, Hamre HJ, Kienle GS. In support of clinical case reports: a system of causality assessment. Global Advances in Health and Medicine. 2013;2:76-87. read 9 October 2026. care-statement.org
- Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D; the CARE Group. The CARE guidelines: consensus-based clinical case reporting guideline development. BMJ Case Reports. 2013:bcr-2013-201554. doi:10.1136/bcr-2013-201554 read 9 October 2026. doi.org/10.1136/bcr-2013-201554
- Carleton HA, Webb ML. The case report in context. Yale Journal of Biology and Medicine. 2012;85(1):93-96. read 9 October 2026. ecancer.org
- Nissen T, Wynn R. The recent history of the clinical case report: a narrative review. JRSM Short Reports. 2012;3:87. read 9 October 2026. cytojournal.com
- Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Advances in Experimental Medicine and Biology. 2010;686:77-86. doi:10.1007/978-90-481-9485-8_5 read 9 October 2026. doi.org/10.1007/978-90-481-9485-8_5
- Albrecht J, Werth VP, Bigby M. The role of case reports in evidence-based practice, with suggestions for improving their reporting. Journal of the American Academy of Dermatology. 2009;60:412-418. read 9 October 2026. asean-endocrinejournal.org
- Dib EG, Kidd MR, Saltman DC. Case reports and the fight against cancer. Journal of Medical Case Reports. 2008;2:39. read 9 October 2026. ecancer.org
- Neely JG, Karni RJ, Nussenbaum B, Paniello RC, Fraley PL, Wang EW, et al. Practical guide to understanding the value of case reports. Otolaryngology-Head and Neck Surgery. 2008;138:261-264. read 9 October 2026. pulmonarychronicles.com
- Mahajan RP, Hunter JM. Volume 100: Case reports: should they be confined to the dustbin? British Journal of Anaesthesia. 2008;100(6):744-746. read 9 October 2026. ecancer.org
- Hauben M, Aronson JK. Gold standards in pharmacovigilance: the use of definitive anecdotal reports of adverse drug reactions as pure gold and high-grade ore. Drug Safety. 2007;30:645-655. read 9 October 2026. care-statement.org
- Albrecht J, Meves A, Bigby M. Case reports and case series from Lancet had significant impact on medical literature. Journal of Clinical Epidemiology. 2005;58:1227-1232. doi:10.1016/j.jclinepi.2005.04.003 read 9 October 2026. doi.org/10.1016/j.jclinepi.2005.04.003
- Patsopoulos NA, Analatos AA, Ioannidis JPA. Relative citation impact of various study designs in the health sciences. JAMA. 2005;293(19):2362-2366. read 9 October 2026. ecancer.org
- Bernhard JD. A case of too many case reports. Journal of the American Academy of Dermatology. 2001;45:773-774. read 9 October 2026. asean-endocrinejournal.org
- Vandenbroucke JP. In defense of case reports and case series. Annals of Internal Medicine. 2001;134(4):330-334. doi:10.7326/0003-4819-134-4-200102200-00017 read 9 October 2026. doi.org/10.7326/0003-4819-134-4-200102200-00017
- Mason RA. The case report: an endangered species? Anaesthesia. 2001;56(2):99-102. read 9 October 2026. ecancer.org
- Vandenbroucke JP. Case reports in an evidence-based world. Journal of the Royal Society of Medicine. 1999;92(4):159-163. read 9 October 2026. ecancer.org
- Centers for Disease Control. Pneumocystis pneumonia - Los Angeles. MMWR Morbidity and Mortality Weekly Report. 1981;30(21):250-252. read 9 October 2026. community.the-hospitalist.org
- Barnard CN. The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. South African Medical Journal. 1967;41(48):1271-1274. read 9 October 2026. ecancer.org
- McBride WG. Thalidomide and congenital abnormalities. The Lancet. 1961;278(7216):1358. doi:10.1016/S0140-6736(61)90927-8 read 9 October 2026. doi.org/10.1016/S0140-6736(61)90927-8
- OCEBM Levels of Evidence. read 9 October 2026. asmapp.mssm.edu
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 9). The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations. Pubrica. https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/
Pubrica Academy. “The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations.” Pubrica, 9 Oct. 2026, pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/.
Pubrica Academy (2026) The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/ (Accessed: 15 October 2026).
Pubrica Academy. “The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations.” Pubrica. October 9, 2026. https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/
Pubrica Academy, ‘The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations’ (Pubrica, 9 October 2026) <https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/> accessed 15 October 2026.
Pubrica Academy. The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations. [Internet]. Pubrica; 2026 Oct 9 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/
Pubrica Academy, “The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations,” Pubrica, Oct. 9, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/
@misc{uses_of_case_reports_in_medical_litera_2026,
author = {{Pubrica Academy}},
title = {The Uses of Case Reports in Medical Literature: Functions and Evidential Limitations},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/uses-of-case-reports-in-medical-literature/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Case report purpose triage
This checklist should be completed before drafting. Its purpose is to make explicit the two decisions that authors usually make implicitly and late: which function the report serves, and what claim it will conclude with.
CASE REPORT PURPOSE TRIAGE
1. WHICH JOB IS THIS REPORT DOING? (tick ONE as primary)
[ ] Detection — not previously described
[ ] Characterisation — known but thinly described
[ ] Falsification — contradicts a stated rule
[ ] Hypothesis generation — association worth testing
[ ] Teaching — clinical reasoning made visible
Primary job: ______________________
Secondary, if any: ______________________
2. THE NOVELTY CLAIM (detection and falsification reports)
Databases searched: ______________________________
Date range and end date: _________________________
Language restrictions: [ ] none [ ] ______________
Search terms used: _______________________________
Number of prior reports found: ______
Claim as it will appear, at the level the search supports:
"________________________________________________"
[ ] The claim is narrowed (first in THIS population / with THIS
exposure / with THIS confirmatory test) rather than absolute
If falsification — the contradicted claim, quoted exactly, with source:
"________________________________________________"
3. STRUCTURED FACTS (the fields that make the report poolable)
Age band and sex as the journal permits: ______________
Relevant comorbidity and concomitant medication: ______
Presentation date / day 0 definition: ________________
Key investigations with values AND units: _____________
Named assay or platform for the confirmatory test: ____
Intervention: agent, dose, route, start and stop dates: _______
Outcome measure, stated explicitly: __________________
Follow-up duration: ______________
[ ] Timeline is reconstructable from the text alone
4. ALTERNATIVE EXPLANATIONS FOR THE COURSE OBSERVED
[ ] Natural history of the condition .......... addressed on page ___
[ ] Concurrent or prior treatments ........... addressed on page ___
[ ] Presentation at the worst point of illness addressed on page ___
[ ] Measurement or assay variation ........... addressed on page ___
[ ] Chance ................................... addressed on page ___
Was treatment withdrawn and reintroduced? [ ] yes [ ] no
If yes, the sequence is reported explicitly as such: [ ]
5. THE CLOSING CLAIM
Write the single strongest claim the case supports:
"________________________________________________"
The study this case would justify:
Population: ______________________
Comparison: ______________________
Outcome: _________________________
Feasible design: _________________
6. SENTENCES TO DELETE IF PRESENT
[ ] "demonstrates that"
[ ] "proves"
[ ] "effective and safe" / "well-tolerated" with no follow-up period
[ ] "clinicians should consider"
[ ] "we recommend"
[ ] any frequency or rate (no denominator exists)
[ ] "to our knowledge the first" with no search described
7. BEFORE SUBMISSION
[ ] CARE items addressed, whether or not the journal requires them
[ ] Patient consent obtained and documented per journal policy
[ ] Identifiers removed, including in images and dates
[ ] Journal article-type definition checked against patient count Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica supports the two elements that most influence the outcome of a case report submission: the novelty claim and the discussion. The team conducts the literature search underlying a “first reported case” statement across multiple databases without language restriction and advises on the level of claim it supports, and identifies every sentence in the discussion that asserts more than a single patient can substantiate. The team also completes the CARE items against the draft and identifies missing structured clinical fields, since these determine whether a report can be used by researchers pooling the literature later.